Today: 23 April 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Mitsubishi UFJ Financial Group (MUFG) Stock Today, November 26, 2025: Price, Buyback Catalyst and Fresh Portfolio Moves

Mitsubishi UFJ Financial Group (MUFG) Stock Today, November 26, 2025: Price, Buyback Catalyst and Fresh Portfolio Moves

MUFG shares traded near $15.50 in New York on Wednesday, just below a 52-week high, after a month of gains driven by earnings and buybacks. The bank disclosed it is no longer a substantial shareholder in Australia’s ADX Energy, following transactions by an entity controlled by Morgan Stanley. MUFG also marked its 20th anniversary on the NYSE this week.
26 November 2025
·
Amphenol Stock Today (APH): Price, Institutional Moves and M&A Outlook on November 26, 2025

Amphenol Stock Today (APH): Price, Institutional Moves and M&A Outlook on November 26, 2025

Amphenol closed Tuesday at $137.81, near its all-time high, after nearly tripling from its 52-week low and gaining about 90% in the past year. Institutional investors now hold roughly 97% of shares, with recent 13F filings showing both new buying and some profit-taking. Market capitalization stands near $169 billion. Trading volume Tuesday was about 7 million shares, below the recent average.
26 November 2025
··
Pfizer (PFE) Stock Today, November 26, 2025: Options Surge, Obesity Bet and Cancer Win Shape the Outlook

Pfizer (PFE) Stock Today, November 26, 2025: Options Surge, Obesity Bet and Cancer Win Shape the Outlook

Pfizer closed Tuesday at $25.72, up nearly 2%, with a dividend yield of about 6.7% and a market cap near $146 billion. Unusual options activity clustered at the $25 strike followed new FDA approval for PADCEV plus Keytruda in bladder cancer and the completed Metsera obesity drug acquisition. Analyst target averages $28.56. Pfizer trades at a forward P/E of about 8.6, with 2025 total return up 3–4% year-to-date.
26 November 2025
··
Royal Caribbean (RCL) Stock Today – November 26, 2025: Price Jump, Fed Hopes, Exclusive Destinations and Black Friday Cruise Demand

Royal Caribbean (RCL) Stock Today – November 26, 2025: Price Jump, Fed Hopes, Exclusive Destinations and Black Friday Cruise Demand

Royal Caribbean shares traded at $266.41 midday Wednesday, up 4.3% after a surge driven by record travel demand and optimism over interest rates. Volume topped 3.8 million shares Tuesday as traders bet on a 2026 Fed rate cut. The stock remains down about 19–28% from recent highs but has gained over 300% since pandemic lows. RCL plans to expand its exclusive destinations portfolio to eight by 2028.
26 November 2025
··
Abbott Laboratories (ABT) Stock Today, November 26, 2025: Insider Sale, $21B Exact Sciences Deal and Libre 3 Sensor Correction in Focus

Abbott Laboratories (ABT) Stock Today, November 26, 2025: Insider Sale, $21B Exact Sciences Deal and Libre 3 Sensor Correction in Focus

Abbott Laboratories shares closed at $128.06 on Tuesday, up 0.66%. Senior Vice President Eric Shroff sold 1,586 shares for about $203,000 that day, according to a Form 4 filing. The company’s market cap stands near $223 billion, with a 52-week range of $110.81 to $141.16. Investors are watching a $21 billion Exact Sciences deal and a safety correction for Libre 3 sensors.
26 November 2025
··
DoorDash (DASH) Stock Today, November 26, 2025: Price Action, Australian Gig‑Worker Deal, Data Breach Fallout and Holiday Push

DoorDash (DASH) Stock Today, November 26, 2025: Price Action, Australian Gig‑Worker Deal, Data Breach Fallout and Holiday Push

DoorDash shares closed at $195.49 on Tuesday, up 3.94%, but remain 31% below their October peak after a sharp selloff following Q3 earnings and increased 2026 investment plans. The company faces a recent data breach, an $18 million legal settlement, and regulatory scrutiny, even as it reports strong order and revenue growth and signs a landmark gig-worker pay deal in Australia.
26 November 2025
··
Palo Alto Networks (PANW) Stock Today, November 26, 2025: Price Action, Chronosphere Deal and Wall Street Outlook

Palo Alto Networks (PANW) Stock Today, November 26, 2025: Price Action, Chronosphere Deal and Wall Street Outlook

Palo Alto Networks closed Tuesday at about $186.3, up 1.3%, after a sharp post-earnings sell-off earlier in November. Shares remain well below the 52-week high of $223.61 and are down roughly 4–6% over the past year. Fiscal Q1 revenue rose 16% to $2.47 billion, with adjusted EPS at $0.93, both above guidance and estimates. Trading volume Tuesday was just under 6 million shares.
26 November 2025
·
Philip Morris International (PM) Stock Rallies 4% as Wall Street Leans Into Smoke‑Free and ESG Story – November 25, 2025

Philip Morris International (PM) Stock Rallies 4% as Wall Street Leans Into Smoke‑Free and ESG Story – November 25, 2025

Philip Morris International shares surged 4.2% to $157.41 Tuesday, outpacing the S&P 500 and Dow after recent corporate updates and a rebound from Monday’s drop. Trading volume hit about 7.2 million shares, above the 50-day average. The stock remains 15–16% below its June 2025 high. CEO Jacek Olczak is set to speak at a Morgan Stanley conference on December 2.
25 November 2025
·
United Airlines (UAL) Stock Today, November 25, 2025: Holiday Travel, Lower Oil and New Risks Lift Shares Toward $99

United Airlines (UAL) Stock Today, November 25, 2025: Holiday Travel, Lower Oil and New Risks Lift Shares Toward $99

United Airlines shares closed at $98.90 on Tuesday, up 3.4%, as investors reacted to record Thanksgiving travel forecasts and lower oil prices. The stock has gained about 7% since Friday and is up roughly 1.9% year to date. United expects to carry 6.6 million passengers over the holiday period, with international bookings up 10% from last year.
25 November 2025
··
Chevron (CVX) Stock Today, November 25, 2025: Seven-Day Slide as Venezuela Supply Deal and Robotics Push Grab Focus

Chevron (CVX) Stock Today, November 25, 2025: Seven-Day Slide as Venezuela Supply Deal and Robotics Push Grab Focus

Chevron shares fell 0.8% to $148.50 on Tuesday, marking a seventh straight decline as oil prices and the S&P 500 Energy sector both dropped. Trading volume was 5–6 million shares, down from last week’s levels. Chevron remains up about 2% for the year. The company is supplying naphtha to Venezuela after a Russian shipment was blocked.
25 November 2025
··
Bank of America (BAC) Stock Rises as Fed Cut Bets Build: All Key News for November 25, 2025

Bank of America (BAC) Stock Rises as Fed Cut Bets Build: All Key News for November 25, 2025

Bank of America shares closed at $52.51 on Tuesday, up 1.1% from Monday, trading near the top of their 12-month range. The move followed renewed bets on Federal Reserve rate cuts and increased institutional buying. The stock’s market cap stands near $379 billion, with a P/E ratio around 14. Futures now price an 85% chance of a Fed rate cut in December.
25 November 2025
··
Opendoor Technologies (OPEN) Stock Today: Warrant Dividend, Fed Rate‑Cut Bets and AI Pivot Drive Volatile Trade on 25 November 2025

Opendoor Technologies (OPEN) Stock Today: Warrant Dividend, Fed Rate‑Cut Bets and AI Pivot Drive Volatile Trade on 25 November 2025

Opendoor shares closed at $7.74 on Tuesday, up 0.65% after a 14% surge Monday on heavy volume. The stock remains more than ten times above its 52-week low but below its recent peak of $10.87. Trading ranged from $7.47 to $8.07 on about 142 million shares. Volatility followed news of a warrant dividend, Fed rate cut speculation, and the company’s AI-driven turnaround plans.
25 November 2025
···
AbbVie (ABBV) Stock Today: Price, Analyst Views, Medicare News and New Biotech Award – November 25, 2025

AbbVie (ABBV) Stock Today: Price, Analyst Views, Medicare News and New Biotech Award – November 25, 2025

AbbVie shares closed at $231.80 on Tuesday, up 1.0%, after U.S. Medicare confirmed plans to negotiate prices on 15 drugs, including AbbVie’s Linzess. The stock saw higher-than-average volume and remains about 5% below its 52-week high. Analysts gave mixed views, with a “Moderate Buy” consensus and a $241.85 average price target. AbbVie also launched a new biotech award program in Quebec.
25 November 2025
·
Intuit (INTU) Stock Today, November 25, 2025: AI Deals, Open Banking Push and Big-Money Buyers Shape the Outlook

Intuit (INTU) Stock Today, November 25, 2025: AI Deals, Open Banking Push and Big-Money Buyers Shape the Outlook

Intuit shares traded just under $650 on Tuesday, down about 0.5%, with an intraday range between $640.55 and $658.47 and a market value near $180 billion. The company launched open-banking data feeds for QuickBooks in Australia, now live with Commonwealth Bank and NAB. Trading volume was in the low-to-mid millions of shares, matching recent averages. Analyst views on near-term momentum remain split.
25 November 2025
·
American Airlines (AAL) Stock Today: Jumps on Holiday Travel Hopes and Fed Rate‑Cut Bets – November 25, 2025

American Airlines (AAL) Stock Today: Jumps on Holiday Travel Hopes and Fed Rate‑Cut Bets – November 25, 2025

American Airlines shares rose over 3% Tuesday afternoon to about $13.54, after hitting an intraday high near $13.78. The move followed forecasts of record Thanksgiving travel, with American planning the most flights of any U.S. carrier. Despite the gain, AAL remains down more than 20% for the year and trades well below its 52-week high. Trading volume topped 57 million shares.
25 November 2025
·
Procter & Gamble (PG) Stock Today, November 25, 2025: Modest Rebound as CFO Webcast, Analyst Targets and Institutional Flows Take Center Stage

Procter & Gamble (PG) Stock Today, November 25, 2025: Modest Rebound as CFO Webcast, Analyst Targets and Institutional Flows Take Center Stage

Procter & Gamble shares traded near $148 Tuesday afternoon, up about 0.9% after Monday’s 2.7% drop, but remain close to 52-week lows. The company confirmed CFO Andre Schulten will speak at a Morgan Stanley conference December 2. Institutional holders showed mixed activity, with about two-thirds of shares held by funds. PG’s market value stands between $340–$350 billion.
25 November 2025
1 … 574 575 576 577 578 … 584

Stock Market Today

  • West Pharmaceutical Services Q1 2026 Earnings Beat Estimates, Shares Surge
    April 23, 2026, 7:34 AM EDT. West Pharmaceutical Services (NYSE:WST) reported strong Q1 CY2026 results, with revenue rising 21% year-on-year to $844.9 million, exceeding analyst estimates by 8.4%. Adjusted earnings per share (EPS) came in at $2.13, beating forecasts by 27.1%. The company raised its full-year revenue guidance to $3.32 billion and adjusted EPS to $8.58. Operating margin improved to 21% from 15.3% last year. CEO Eric M. Green attributed growth to increased demand and successful production expansion, particularly in Europe. Despite a solid quarter, the company's longer-term revenue growth has moderated, with a 6.7% CAGR over five years and a slowdown to 4.9% in the past two years, raising some caution on future momentum.

Latest article

Heineken Beats Q1 Revenue Forecasts, Keeps 2026 Outlook Despite Beer Volume Dip

Heineken Beats Q1 Revenue Forecasts, Keeps 2026 Outlook Despite Beer Volume Dip

23 April 2026
Heineken reported a 2.8% rise in first-quarter organic net revenue, beating forecasts, but beer volumes fell 0.8% and shares dropped nearly 3%. Weakness persisted in Europe and the Americas, while Asia Pacific saw gains. The company kept its full-year profit outlook and gave no update on a successor to CEO Dolf van den Brink, who steps down May 31.
Tesla Q1 Earnings: Profit Beats Estimates on $22.4 Billion Revenue, but Musk’s Spending Surge Raises the Stakes

Tesla Q1 Earnings: Profit Beats Estimates on $22.4 Billion Revenue, but Musk’s Spending Surge Raises the Stakes

23 April 2026
Tesla reported first-quarter revenue of $22.39 billion and net income of $477 million, beating profit expectations despite weak vehicle deliveries and rising inventory. Adjusted earnings per share were 41 cents. Free cash flow reached $1.44 billion, but the company warned it would likely turn negative for the rest of 2026. Tesla increased its capital spending forecast to over $25 billion for the year.
Gold eases from one-week bounce as Iran truce holds and Warsh signals hawkish tilt

Gold eases from one-week bounce as Iran truce holds and Warsh signals hawkish tilt

23 April 2026
Gold fell 0.8% to $4,701/oz in early Asian trade Thursday, reversing much of Tuesday’s gain as an extended U.S.-Iran ceasefire reduced safe-haven demand. The dollar index rose to 98.57 and U.S. 10-year yields hit 4.31% after hawkish comments from Fed chair nominee Kevin Warsh. Gold remains about 13% below its January record high but is up 8% year-to-date. Traders await the April 28–29 FOMC meeting.
Go toTop